Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

ZD1839 can cause skin issues like acne and hair changes.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Nilotinib can cause generalized keratosis pilaris.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Terbinafine can cause skin reactions when exposed to sunlight, so sun exposure should be avoided during treatment.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

The sensor accurately measures thallium ions in solutions with high selectivity.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Oral itraconazole effectively reaches and treats deep skin layers in guinea pigs.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Nilotinib can cause keratosis pilaris, a skin condition.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Talquetamab may cause hair loss and skin issues.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.